Embed Size (px)
Citation preview
assay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agility
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
OUR SERVICES
Integrated solutions: extensive track record developing/transferring, qualifying and validating clinical tests ranging from preclinical to clinical Phase I – IV.
Protein sciences: molecular biology, protein expression, protein puri�cation and structural/physicochemical characterization.
Immunochemistry: single and multiplex immunochemistry assays for preclinical and clinical quanti�cation of humoral responses.
Functional assays: viral and bacterial manual and automated assays to evaluate the level of neutralizing antibodies generated in vaccine trials.
Cell-based immunology: cellular immunology assays to monitor immune cells during preclinical studies or clinical trials.
Bioanalytical services: bioanalytical/immunogenicity support through all phases of assay development/transfer, validation and testing.
Fit-for-purpose biomarkers: Cardiovascular, Metabolic Diseases, Chronic Liver Disease, Acute Kidney Injury, Musculoskeletal, In�ammation (including Oncology and Neurology) and Nutritional Health.
In vivo models: support to the development of multiple vaccines, immunotherapeutics, or other biologically-active molecules.
assay development and high-throughput sample testing
OUR LEGACY REPRESENTS OUR STRENGTH
Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship.
Today, with uni�ed management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 30 years of biomarker experience.
In Canada, we emerged from GSK as NEOMED-LABS with extensive knowledge and a deep understanding of the pharma mindset.
In the United States, we grew from a University of Washington research unit to earn wide respect as Paci�c Biomarkers.
More recently, we were joined by PAIRimmune, a knowledgeable CRO with major preclinical expertise.
NEOMED-LABS
Paci�c Biomarkers
PAIRimmune
OUR NAME REPRESENTS OUR VISION
We are the next generation of contract research organization, born when companies of global stature agreed to unify and advance to new levels of dynamic management and fast-track sophistication.
We have deep expertise in the disciplined �eld of vaccines, large molecules, immunotherapies and biomarkers, with a strong reputation for accelerated results, enabled by state-of-the-art platforms.
We excel by combining robust protocols with scienti�c discipline, human agility and client partnership in order to answer the most demanding mission requirements.
next
excel
immuno-science
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
assay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agility
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
Welcome to a unique balance of world-class standards and human-scale collaboration.
Welcome to the highest levels of scienti�c discipline, aided by advanced facilities and cutting-edge technology.
Welcome to unrivalled agility, the advantage of critical thinking from open minds that enables us to compress time and achieve results.
FOR MORE INFORMATION
Please contact:
Mounia Azzi, PhDC 1 514 [email protected]
nexelis.com
OUR SYMBOL REPRESENTS OUR PRINCIPLES
we believe that success in our �eld is best achieved by a fusion of scienti�c discipline, human agility and client partnership.
we believe that together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.
human agilityDynamism, collaboration, ingenuity, critical thinking, open minds.
scienti�c disciplineKnowledge, diligence, focus, innovation,
high throughput.
client partnershipFriendliness, transparency, integrity,
proactivity, accountability.
disciplined agilityassay development specialty testing
